Dorsal Raphe Serotonergic Neurons In Lewy Body Disease is a cell type relevant to neurodegenerative disease research. This page covers its role in brain function, involvement in disease processes, and significance for therapeutic strategies.
The Dorsal Raphe Nucleus (DRN) is the primary source of serotonergic innervation to the forebrain, playing crucial roles in mood regulation, sleep, and pain processing. In Lewy body disease, DRN serotonergic neurons undergo significant degeneration, contributing to depression, sleep disorders, and anxiety.
DRN dysfunction contributes to:
| Parameter | Change | Clinical Impact |
|---|---|---|
| 5-HT tissue | ↓↓ 40-60% | Depression |
| 5-HIAA CSF | ↓ 30-50% | Disease severity |
| 5-HT1A receptors | ↑ (compensation) | Anxiety |
| 5-HT2A receptors | ↓ | Psychosis |
The study of Dorsal Raphe Serotonergic Neurons In Lewy Body Disease has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Halliday, G.M., et al. (1990). Dorsal Raphe Nucleus in Parkinson's Disease. Annals of Neurology.
[2] Braak, H., et al. (2003). Raphe Serotonergic Pathology in LBD. Acta Neuropathologica.
[3] Sharp, S.I., et al. (2006). Depression in Parkinson's Disease. Journal of Neurology, Neurosurgery & Psychiatry.
[4] Politis, M., et al. (2010). Serotonin Dysfunction in PD. Brain.
[5] Qiu, J.H., et al. (2019). DRN Pathology in LBD. Journal of Neuropathology & Experimental Neurology.